Atara Biotherapeutics, Inc.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Aug 18, 2025
144 Aug 18, 2025
10-Q Aug 11, 2025 10-Q
8-K Aug 11, 2025 8-K
4 Jul 21, 2025 4
8-K Jul 14, 2025 8-K
4 Jun 12, 2025
4 Jun 12, 2025
4 Jun 12, 2025
4 Jun 12, 2025
4 Jun 12, 2025
4 Jun 12, 2025
8-K Jun 11, 2025 8-K
SCHEDULE 13D May 23, 2025
3 May 23, 2025 OWNERSHIP DOCUMENT
3 May 23, 2025 OWNERSHIP DOCUMENT
3 May 21, 2025 3
SCHEDULE 13D May 21, 2025
4 May 20, 2025
4 May 20, 2025
144 May 16, 2025
144 May 16, 2025
SCHEDULE 13D/A May 16, 2025
4 May 16, 2025 OWNERSHIP DOCUMENT
8-K May 16, 2025 8-K
← Newer Page 4 of 46 · 1130 filings Older →